Carl Ashley Morris - Jan 3, 2023 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Chief Scientific Officer
Signature
/s/ David Tyronne Howton as attorney-in-fact for Carl Ashley Morris
Stock symbol
SLDB
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 08:46 PM
Previous filing
May 4, 2022
Next filing
Jan 31, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Employee Stock Option (Right to Buy) Award $0 +95.1K $0.00 95.1K Jan 3, 2023 Common Stock 95.1K $5.62 Direct F1
transaction SLDB Restricted Stock Units Award $0 +47.6K $0.00 47.6K Jan 3, 2023 Common Stock 47.6K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 3, 2023 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares on the first day of each calendar month thereafter until the fourth such anniversary.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
F3 The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Remarks:

Exhibit Index: 24.1 Power of Attorney